{"9VO.F": {"short_name": "VOLUNTIS S.A.  EO-,10", "long_name": "Voluntis S.A.", "summary": "Voluntis S.A. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas in France and the United States. It offers Insulia, a prescription medical device that provides automated basal insulin dose recommendations and coaching messages for people with type 2 diabetes; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. The company provides Oleena, a first FDA class II software-as-a-medical device for cancer indications; AstraZeneca, an e-Cediranib Olaparib application designed for patient self-reporting and management of hypertension and diarrhea; Theraxium Oncology, a cornerstone software platform for all digital therapeutics of cancer treatment, as well as coagulation and hemophilia solutions. Voluntis S.A. has a collaboration agreement with Bristol-Myers Squibb Company to co-develop digital Therapeutics for Oncology. Voluntis S.A. was founded in 2001 and is based in Suresnes, France.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "FRA", "market": "dr_market", "country": "France", "city": "Suresnes"}, "ALINS.PA": {"short_name": "INTRASENSE", "long_name": "Intrasense SA", "summary": "Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, research labs, and spin-offs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Prostate; Myrian XP-Breast; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams. The company was founded in 2004 and is headquartered in Montpellier, France.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "PAR", "market": "fr_market", "country": "France", "city": "Montpellier"}, "C7E.F": {"short_name": "CEGEDIM SA  EO 0,9528", "long_name": "Cegedim SA", "summary": "Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B marketing, and business software for healthcare and insurance professionals worldwide. It operates through two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also offers software and services for health insurers; flows, electronic payment, and management services; and outsourced payroll and human resources management services, as well as electronic data exchange services. In addition, it provides digital marketing tools to doctors, pharmacists, and allied health professionals; digital displays in pharmacies, and health and wellness shops; digitization of business, accounting, financial, and communication data flows; data and analytics for the healthcare industry; and other services, including the management of medical samples and promotional materials, healthcare data hosting, and integration and services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was founded in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "FRA", "market": "dr_market", "country": "France", "city": "Boulogne-Billancourt"}, "CGM.PA": {"short_name": "CEGEDIM", "long_name": "Cegedim SA", "summary": "Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B marketing, and business software for healthcare and insurance professionals worldwide. It operates through two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also offers software and services for health insurers; flows, electronic payment, and management services; and outsourced payroll and human resources management services, as well as electronic data exchange services. In addition, it provides digital marketing tools to doctors, pharmacists, and allied health professionals; digital displays in pharmacies, and health and wellness shops; digitization of business, accounting, financial, and communication data flows; data and analytics for the healthcare industry; and other services, including the management of medical samples and promotional materials, healthcare data hosting, and integration and services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was founded in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "PAR", "market": "fr_market", "country": "France", "city": "Boulogne-Billancourt"}, "PHF.F": {"short_name": "PHARMAGEST INT.INH.EO 0,2", "long_name": "Pharmagest Interactive SA", "summary": "Pharmagest Interactive SA engages in the development and commercialization of IT solutions for pharmacies and the pharmaceutical industry in Europe. It offers solution for managing pharmacies and their networks, such as LGPI global services and OffCentral; security solutions for pharmacists' business processes, such as OffMSS, OffSecure, DomiSecure, OffProtect, OffPass, OffSeen, OffCash, and Offzzy; solutions for energising the customer relationship with pharmacists, including OffTag, OffTouch, OffM\u00c3\u00a9dia, and OffConnect, as well as automation systems, such as SELLEN, SELLEN TWIST, and SINTESI robots that optimize the available space and free up the pharmacies team to advise customers; and customer loyalty programmes. The company also provides My Pilot, an analytics and management tool equipped with dashboards; OffLearning, e-learning tool; solutions for patient support and advice, such as the compliance monitoring software, Ma Pharmacie Mobile, Multimeds, Automeds, OffT\u00c3\u00a9l\u00c3\u00a9consult, as well as provides pharmaceutical record and shared medical record. In addition, it offers a range of PHARMAGEST BELGIUM software for the pharmacies in Belgium; OFFICINE 2016 pharmacy software management suite for Luxembourg; TITAN, an integrated and modular software suite for elderly residential care homes, day care and sheltered housing facilities for persons with disabilities. Further, the company provides hospital-at-home solutions, such as ANTHADINE and MOBISOINS; MICROSOINS, an in-home nursing care solution; and LOGICLIC that provides services for local information and coordination centres. Additionally, it offers equipment lease financing solutions; and IT equipment and services to wholesale distributors, such as DIFARM, FARMACLICK, PHARE, and SOPHIA. The company was founded in 1996 and is based in Villers-les-Nancy, France. Pharmagest Interactive SA is a subsidiary of Marque Verte Sante.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "FRA", "market": "dr_market", "country": "France", "city": "Villers-l\u00c3\u00a8s-Nancy"}, "SDT.PA": {"short_name": "VISIODENT", "long_name": "Visiodent S.A.", "summary": "Visiodent S.A. engages in the digital imaging and dental software businesses worldwide. The company offers phosphor plates scanners under the ISCAN brand name; RSV5 sensor systems; Visiocam 4 cameras; and dental imaging software under the Visiodent Imaging brand. Visiodent S.A. offers its products through distributors. The company was founded in 1982 and is based in La Plaine Saint-Denis, France. Visiodent S.A. is a subsidiary of Groupe Visiodent SAS.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "PAR", "market": "fr_market", "country": "France", "city": "La Plaine Saint-Denis"}, "VOT.SG": {"short_name": "VISIODENT S.A. Actions Port. EO", "long_name": "Visiodent S.A.", "summary": "Visiodent S.A. engages in the digital imaging and dental software businesses worldwide. The company offers phosphor plates scanners under the ISCAN brand name; RSV5 sensor systems; Visiocam 4 cameras; and dental imaging software under the Visiodent Imaging brand. Visiodent S.A. offers its products through distributors. The company was founded in 1982 and is based in La Plaine Saint-Denis, France. Visiodent S.A. is a subsidiary of Groupe Visiodent SAS.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "STU", "market": "dr_market", "country": "France", "city": "La Plaine Saint-Denis"}, "VTX.PA": {"short_name": "VOLUNTIS", "long_name": "Voluntis S.A.", "summary": "Voluntis S.A. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas in France and the United States. It offers Insulia, a prescription medical device that provides automated basal insulin dose recommendations and coaching messages for people with type 2 diabetes; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. The company provides Oleena, a first FDA class II software-as-a-medical device for cancer indications; AstraZeneca, an e-Cediranib Olaparib application designed for patient self-reporting and management of hypertension and diarrhea; Theraxium Oncology, a cornerstone software platform for all digital therapeutics of cancer treatment, as well as coagulation and hemophilia solutions. Voluntis S.A. has a collaboration agreement with Bristol-Myers Squibb Company to co-develop digital Therapeutics for Oncology. Voluntis S.A. was founded in 2001 and is based in Suresnes, France.", "currency": "EUR", "sector": "Healthcare", "industry": "Health Information Services", "exchange": "PAR", "market": "fr_market", "country": "France", "city": "Suresnes"}}